Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonists

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Epple, R.
  • Cow, C.
  • Xie, Y. P.
  • Azimioara, M.
  • Russo, R.
  • Wang, X.
  • Wityak, J.
  • Karanewsky, D. S.
  • Tuntland, T.
  • Nguyen-Tran, V. T. B.
  • Ngo, C. C.
  • Huang, Dee-Hua
  • Saez, Enrique
  • Spalding, T.
  • Gerken, A.
  • Iskandar, M.
  • Seidel, H. M.
  • Tian, S. S.

publication date

  • January 2010

journal

  • Journal of Medicinal Chemistry  Journal

abstract

  • The discovery, synthesis, and optimization of compound 1 from a high-throughput screening hit to highly potent and selective peroxisome proliferator-activated receptor delta (PPARdelta) agonists are reported. The synthesis and structure-activity relationship in this series are described in detail. On the basis of a general schematic PPAR pharmacophore model, scaffold 1 was divided into headgroup, linker, and tailgroup and successively optimized for PPAR activation using in vitro PPAR transactivation assays. A (2-methylphenoxy)acetic acid headgroup, a flexible linker, and a five-membered heteroaromatic center ring with two hydrophobic aryl substituents were required for efficient and selective PPARdelta activation. The fine-tuning of these aryl substituents led to an array of highly potent and selective compounds such as compound 38c, displaying an excellent pharmacokinetic profile in mouse. In an in vivo acute dosing model, selected members of this array were shown to induce the expression of pyruvate dehydrogenase kinase-4 (PDK4) and uncoupling protein-3 (UCP3), genes that are known to be involved in energy homeostasis and regulated by PPARdelta in skeletal muscle.

subject areas

  • Animals
  • Drug Evaluation, Preclinical
  • Fluorescence Resonance Energy Transfer
  • High-Throughput Screening Assays
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Molecular Structure
  • Oxazoles
  • PPAR delta
  • Stereoisomerism
  • Structure-Activity Relationship
  • Thiazoles
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0022-2623

Digital Object Identifier (DOI)

  • 10.1021/jm9007399

PubMed ID

  • 19928766
scroll to property group menus

Additional Document Info

start page

  • 77

end page

  • 105

volume

  • 53

issue

  • 1

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support